$200 AUD). This is looking like an expensive way as a precaution to monitor health. Get that if prescribed or you have a significant health concern cost becomes less of an issue.
We really want the initial 1000 devices sold to start getting the recurring revenue. It may take at these prices for the devices to move and for the next 10000 device PO to arrive.
Hope I'm wrong and the AGM tells us the actual quantity of devices and remote monitoring numbers. Not sure I trust our board to share this level of information.
- Forums
- ASX - By Stock
- Ann: Maiden purchase order received for Prizma device in Italy
$200 AUD). This is looking like an expensive way as a precaution...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online